28
Oct
2025

Anemocyte S.r.l.

Exhibitor at CPHI Frankfurt 2025 stand 4.1M42, Bioproduction
About Us

Anemocyte, a Biotech Manufacturing Organization based in Italy, offers development and manufacturing services and innovative solutions from R&D to GMP to address needs in the field of: - pDNA - Plasmids for Viral Vector and RNA manufacturing; - mRNA ' mRNA manufacturing for Vaccines and Therapies. Our experience: > 20 years of manufacturing innovative Therapies. Meet us at the Bio Production zone at booth #3D105!

  • IT
  • 2018
    On CPHI since
  • 1
    Certificates
  • 50 - 99
    Employees
Company types
Other
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 4.1M42, Bioproduction

Products Featured at CPHI Frankfurt 2025

  • mRNA

    Product mRNA

    mRNA can be used for: - Vaccines; - Immuno-oncology therapies; - Protein replacement therapies; - Genetic diseases. MANUFACTURING Highlights Starting from 1 mL batch size QUALITY Highlights - Production and analysis are performed in ISO certified laboratories; - All the equipment for production and anal...
  • Cell therapy manufacturing

    Product Cell therapy manufacturing

    Development, optimization and GMP manufacturing of cell therapy products. 

    Manufacturing Highlights:

    • Manufacturing of autologous and allogeneic cell therapy products.• Non-viral gene modification.
    • Process an...
  • Plasmid DNA

    Product Plasmid DNA

    Manufacturing of plasmid DNA as starting material for:

    • Clinical manufacturing of gene and immuno-oncology therapies, for example in AAV or lentiviral vector.
    • Clinical manufacturing of biological drugs.

    Quality Highlights:
    ...